The current valuation score of Pacira Biosciences Inc is 8.28, ranking 61 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 209.75, which is 11.46% below the recent high of 233.78 and 279.99% above the recent low of -377.53.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.